GOLDSTEIN DOV A MD sold BIOA
January 13, 2026 · Form 4 insider transaction
GOLDSTEIN DOV A MD sold 1,923 shares of BioAge Labs, Inc. at $21.08 per share, a transaction worth $40.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,923
Price
$21.08
Total value
$40.5K
InsiderGOLDSTEIN DOV A MD
RoleOfficer, Director
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 13, 2026
Filing dateJanuary 15, 2026
Shares owned after22,408
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.04 to $21.15 per share, inclusive.